Methods of treating hepatocellular carcinoma with denspm
AssigneesGenzyme Corporation, University of Florida Research Foundation, Inc.
InventorsDavid Davidson, Raymond Bergeron
Life of this patent
Estimating the term…
Abstract
The disclosure provides methods for treating hepatocellular carcinoma. The methods include administering to a subject an effective amount of DENSPM to treat the hepatocellular carcinoma.
Claims30
A method of treating hepatocellular carcinoma comprising administering to a subject in need thereof an amount of DENSPM or a pharmaceutically-acceptable salt thereof effective to treat the hepatocellular carcinoma.
A method of treating hepatocellular carcinoma comprising administering to a subject in need thereof a 28-day therapeutic regimen, said regimen comprising administration of DENSPM or a pharmaceutically-acceptable salt thereof on days 1, 3, 5, 8, 10 and 12, followed by 16 days without DENSPM administration to said subject.
Dependencies are inferred from the claim text.